NYSE:MCK
McKesson Corporation Stock News
$559.91
+4.79 (+0.86%)
At Close: May 10, 2024
Are Investors Undervaluing McKesson (MCK) Right Now?
10:46am, Wednesday, 28'th Feb 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
12:11pm, Tuesday, 27'th Feb 2024
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
Here's Why McKesson (MCK) is a Strong Value Stock
10:41am, Tuesday, 20'th Feb 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
McKesson: GLP-1 Contributed More Than 1/3 Of Growth
03:22am, Monday, 19'th Feb 2024
McKesson reported 15% topline growth and 12.2% adjusted EPS growth in their recent earnings report. The company's GLP-1 medications have shown impressive growth, contributing 60% to year-over-year gro
3 Attractive Medical Stocks to Buy After Earnings
04:56pm, Thursday, 08'th Feb 2024
Following their favorable quarterly results this week here are three intriguing healthcare stocks that investors will want to consider.
McKesson (MCK) Beats on Q3 Earnings, Raises FY24 EPS View
10:31am, Thursday, 08'th Feb 2024
McKesson's (MCK) third-quarter fiscal 2024 results benefit from growth in the United States. Divestment hurts the International segment.
Here's What Key Metrics Tell Us About McKesson (MCK) Q3 Earnings
07:00pm, Wednesday, 07'th Feb 2024
The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estim
McKesson raises annual profit forecast on strong demand for specialty medicines
06:30pm, Wednesday, 07'th Feb 2024
U.S.-based drug distributor McKesson raised its annual profit forecast on Wednesday, banking on strong demand for specialty medicines.
5 Dividend Growth Stocks to Buy for a Safe Portfolio
08:41am, Tuesday, 06'th Feb 2024
Installed Building Products (IBP), PACCAR. (PCAR), McKesson (MCK), Republic Services (RSG) and PulteGroup (PHM) seem solid choices for a safe portfolio amid the current market volatility.
McKesson Corporation (MCK) Hits Fresh High: Is There Still Room to Run?
10:16am, Monday, 05'th Feb 2024
McKesson (MCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Exploring Analyst Estimates for McKesson (MCK) Q3 Earnings, Beyond Revenue and EPS
10:21am, Friday, 02'nd Feb 2024
Evaluate the expected performance of McKesson (MCK) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics
McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:05am, Wednesday, 31'st Jan 2024
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why McKesson (MCK) is a Strong Value Stock
10:41am, Wednesday, 31'st Jan 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
3 Hidden Healthcare Stocks Poised for a Breakout This Year
12:31pm, Tuesday, 30'th Jan 2024
One of the most important sectors not only in the financial markets but also in everyone's life, is the healthcare sector. It can provide investors with good returns due to its constant growth and con
Should Value Investors Buy McKesson (MCK) Stock?
10:46am, Thursday, 25'th Jan 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest